7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT 3 receptor expression via acetate production

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We found that gut microbiota alters serotonin (5-HT)-evoked intestinal secretion in a 5-HT 3 receptor-dependent mechanism and gut microbiota metabolite acetate alters 5-HT 3 receptor expression in colonoids.

          Abstract

          Serotonin [5-hydroxytryptamine (5-HT)], an important neurotransmitter and a paracrine messenger in the gastrointestinal tract, regulates intestinal secretion by its action primarily on 5-HT 3 and 5-HT 4 receptors. Recent studies highlight the role of gut microbiota in 5-HT biosynthesis. In this study, we determine whether human-derived gut microbiota affects host secretory response to 5-HT and 5-HT receptor expression. We used proximal colonic mucosa-submucosa preparation from age-matched Swiss Webster germ-free (GF) and humanized (HM; ex-GF colonized with human gut microbiota) mice. 5-HT evoked a significantly greater increase in short-circuit current (Δ I sc) in GF compared with HM mice. Additionally, 5-HT 3 receptor mRNA and protein expression was significantly higher in GF compared with HM mice. Ondansetron, a 5-HT 3 receptor antagonist, inhibited 5-HT-evoked Δ I sc in GF mice but not in HM mice. Furthermore, a 5-HT 3 receptor-selective agonist, 2-methyl-5-hydroxytryptamine hydrochloride, evoked a significantly higher Δ I sc in GF compared with HM mice. Immunohistochemistry in 5-HT 3A-green fluorescent protein mice localized 5-HT 3 receptor expression to enterochromaffin cells in addition to nerve fibers. The significant difference in 5-HT-evoked Δ I sc between GF and HM mice persisted in the presence of tetrodotoxin (TTX) but was lost after ondansetron application in the presence of TTX. Application of acetate (10 mM) significantly lowered 5-HT 3 receptor mRNA in GF mouse colonoids. We conclude that host secretory response to 5-HT may be modulated by gut microbiota regulation of 5-HT 3 receptor expression via acetate production. Epithelial 5-HT 3 receptor may function as a mediator of gut microbiota-driven change in intestinal secretion.

          NEW & NOTEWORTHY We found that gut microbiota alters serotonin (5-HT)-evoked intestinal secretion in a 5-HT 3 receptor-dependent mechanism and gut microbiota metabolite acetate alters 5-HT 3 receptor expression in colonoids.

          View this article's corresponding video summary at https://www.youtube.com/watch?v=aOMYJMuLTcw&feature=youtu.be.

          Related collections

          Author and article information

          Journal
          Am J Physiol Gastrointest Liver Physiol
          Am. J. Physiol. Gastrointest. Liver Physiol
          ajpgi
          ajpgi
          AJPGI
          American Journal of Physiology - Gastrointestinal and Liver Physiology
          American Physiological Society (Bethesda, MD )
          0193-1857
          1522-1547
          1 July 2017
          13 April 2017
          1 July 2018
          : 313
          : 1
          : G80-G87
          Affiliations
          [1] 1Division of Gastroenterology and Hepatology, Mayo Clinic , Rochester, Minnesota;
          [2] 2Department of Otolaryngology, University of Colorado School of Medicine , Aurora, Colorado; and
          [3] 3Department of Physiology and Biomedical Engineering, Mayo Clinic , Rochester, Minnesota
          Author notes
          Address for reprint requests and other correspondence: P. C. Kashyap, Div. of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905 (e-mail: kashyap.purna@ 123456mayo.edu ).
          Article
          PMC5538830 PMC5538830 5538830 GI-00448-2016 GI-00448-2016
          10.1152/ajpgi.00448.2016
          5538830
          28408644
          606f2500-2098-4939-90ba-eccfc4727d7d
          Copyright © 2017 the American Physiological Society
          History
          : 27 December 2016
          : 28 March 2017
          : 5 April 2017
          Funding
          Funded by: http://doi.org/10.13039/100000062 HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
          Award ID: DK100638
          Award ID: DK103911
          Award ID: DK106456
          Funded by: global probiotic council
          Funded by: Center for Individualized Medicine, Mayo Clinic, Rochester, MN
          Categories
          Research Article
          Neurogastroenterology and Motility

          irritable bowel syndrome,microbiome,motility,physiology,secretion,5-hydroxytryptamine type 3

          Comments

          Comment on this article